The morbidly adherent placenta: Diagnosis and management options

Current Opinion in Obstetrics and Gynecology

Volumn 23, Issue 6, 2011, Pages 448-453

  Hayes, Ellen ^a   Ayida, Gubby ^a   Crocker, Alison ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

caesarean hysterectomy; conservative management; morbidly adherent placenta; placenta accreta

Indexed keywords

CHORIONIC GONADOTROPIN; METHOTREXATE;

ABDOMINAL PAIN; ARTERY PERFORATION; ARTERY THROMBOSIS; ARTIFICIAL EMBOLISM; BALLOON CATHETER; BLOOD TRANSFUSION; CESAREAN SECTION; CURETTAGE; ECHOGRAPHY; FEMALE; FEVER; FOLLOW UP; HEMATOMA; HORMONE BLOOD LEVEL; HUMAN; HYSTERECTOMY; INTERNAL ILIAC ARTERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS PAIN SYNDROME; PLACENTA ACCRETA; PLACENTA PREVIA; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; ULTRASOUND;

ABORTIFACIENT AGENTS, NONSTEROIDAL; BALLOON DILATION; CESAREAN SECTION; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; HYSTERECTOMY; METHOTREXATE; PATIENT CARE TEAM; PLACENTA ACCRETA; POSTOPERATIVE CARE; POSTPARTUM HEMORRHAGE; PREGNANCY;

EID: 81255158699     PISSN: 1040872X     EISSN: 1473656X     Source Type: Journal    
DOI: 10.1097/GCO.0b013e32834cef7a     Document Type: Review

References (47)

1. Orbach A, Levy A, Wiznitzer A, et al. Peripartum caesarean hysterectomy: critical analysis of risk factors and trends over the years. JMatern Fetal Neonat Med 2011; 24:480-484.
2. Eller AG, Porter TF, Soisson P, Silver RM. Optimum management strategies for placenta accreta. BJOG 2009; 116:648-654.
3. Silver R. Delivery after previous caesarean: long-term maternal outcomes. Semin Perinatol 2010; 34:258-266.
4. Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat caesarean deliveries. Obstet Gynecol 2006; 107:1226-1232.
5. Martin JA, Hamilton BE, Sutton PD, et al. Births: final data for 2006. Natl Vital Stat Rep 2009. www.cdc.gov/nchs/data/nvsr/nvsr57/nvsr57-07.pdf. [Accessed 27 April 2009]
6. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty year analysis. Am J Obstet Gynecol 2005; 192:1458-1461.
7. Stafford I, Belfort M. Placenta accreta, increta, and percreta: a team based approach starts with prevention. Contemp Obstet Gynecol 2008; 53:76-82.
8. Doumouchtis S, Arulkumaran S. The morbidly adherent placenta: an overview of management options. Acta Obstet Gynecol 2010; 89:1126-1133.
9. Warshak CR, Eskander R, Hull AD, et al. Accuracy of ultrasonography and magnetic resonance imaging in diagnosing placenta accreta. Obstet Gynaecol 2006; 108:573-581.
10. Dwyer BK, Belogolovkin V, Tran L, et al. Prenatal diagnosis of placenta accreta: sonography or magnetic resonance imaging? J Ultrasound Med 2008; 27:1275-1281.
11. Chou MM, Ho ESC, Lee YH. Prenatal diagnosis of placenta praevia accrete by transabdominal colour Doppler ultrasound. Ultrasound Obstet Gynecol 2000; 15:28-35.
12. Zhang L, Li P, He GL, et al. Value of prenatal diagnosis of placenta praevia with placenta increta by transabdominal colour Doppler ultrasound. Zhonghua Fu Chan Ke Za Zhi 2006; 41:799-802.
13. Esakoff T, Sparks T, Kaimal A, et al. Diagnosis and morbidity of placenta accreta. Ultrasound Obstet Gynecol 2011; 37:324-327.
14. Elsayes KM, Trout AT, Friedkin AM, et al. Imaging of the placenta: a multimodality pictorial review. RadioGraphics 2009; 29:1371-1391.
15. Baughman WC, Corteville JE, Shah RR. Placenta accreta: spectrum of US and MR findings. RadioGraphics 2008; 28:1905-1916.
16. Comstock CH, Love JJ Jr, Bronsteen RA, et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynaecol 2004; 190:1135-1140.
17. Royal College of Obstetricians and Gynaecologists. Green-top Guideline No. 27: Placenta praevia, placenta praevia accreta and vasa praevia: diagnosis and management. London: RCOG; 2011.
18. Eller AG, Bennett MA, Sharshiner M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisiplinary care team compared with standard obstetric care. Obstet Gynaecol 2011; 117:331-337.
19. O'Brien D, Babiker E, O'Sullivan O, et al. Prediction of peripartum hysterectomy and end organ dysfunction in major obstetric haemorrhage. Eur J Obstet Gynecol Reprod Biol 2010; 153:165-169.
20. Lewis G, editor. The confidential enquiry into maternal and child health (CEMACH).Saving mother's lives: reviewing maternal deaths to make motherhood safer 2003-2005. The seventh report of the confidential enquiries into Maternal Deaths in the UK. London: CEMACH: 2007.
21. Bergakker S. Case report: management of elective cesarean delivery in the presence of placenta previa and placenta accreta. AANA J 2010; 78:380-384.
22. Robinson B, Grobman W. Effectiveness of timing strategies for delivery of individuals with placenta praevia and accreta. Obstet Gynaecol 2010; 116:835-842.
23. Royal College of Obstetricians and Gynaecologists. Green-top Guideline No.7: antenatal corticosteroids to reduce neonatal morbidity and mortality. London: RCOG; 2010.
24. Yap YY, Perrin LC, Pain SR, et al. Manual removal of suspected placenta accreta at caesarean hysterectomy. Int J Gynaecol Obstet 2008; 100:186-187.
25. Timmermans S, van Hof AC, Duvekot JJ. Conservative management of abnormally invasive placentation. Obstet Gynecol Surv 2007; 62:529-539.
26. Sentilhes L, Kayem G, Ambroselli C, et al. Fertility and pregnancy outcomes following conservative treatment for placenta accreta. Hum Reprod 2010; 25:2803-2810.
27. Lee P, Bakelaar R, Fitpatrick C, et al. Medical and surgical treatment of placenta percreta to optimise bladder preservation. Obstet Gynaecol 2008; 112:421-424.
28. Washecka R, Behling A. Urologic complications of placenta percreta invading the urinary bladder: a case report and review of the literature. Hawaii Med J 2002; 61:66-69.
29. Cho FN, Liu CB, Li JY, Chen SN. Complete resolution of diffuse placenta increta in a primigravida with twin pregnancy: sonographic monitoring. J Clin Ultrasound 2011; 39:363-366.
30. Mahendru R, Taneja BK, Malik S. Preservation of fertility following abnormally adherent placenta treated conservatively: a case report. Cases J 2009; 2:9349.
31. Russell NE, Gleeson V, Robson M, et al. Conservative management of placenta accreta. Ir Med J 2009; 102:232-233.
32. Hays A, Worley KC, Roberts SR, CunninghamFG. Conservative management of placenta percreta. Obstet Gynecol 2008; 112:425-426.
33. Sidhu HK, Prasad G, Jain V, et al. Pelvic artery embolisation in the management of obstetric haemorrhage. Acta Obstet Gynecol Scand 2010; 89:1096-1099.
34. Park J, Shin T, Baek J, et al. Failure of uterine artery embolisation for controlling postpartum haemorrhage. J Obstet Gynaecol Res 2011; 37:971-978.
35. Bishop S, Butler S, Monaghan S, et al. Multiple complications following the use of prophylactic internal iliac artery balloon catheterisation in a patient with placenta percreta. Int J Obstet Anesth 2011; 20:70-73.
36. Sivan E, Spira M, Achiron R, et al. Prophylactic pelvic artery catheterization and embolisation in women with placenta accreta: Can it prevent caesarean hysterectomy? Am J Perinatol 2010; 27:455-461.
37. Thon S, Mclintic A, Wagner Y. Prophylactic endovascular placement of internal iliac occlusion balloon catheters in patients with placenta accreta: a retrospective case series. Int J Obstet Anaesth 2011; 20:64-88.
38. Soyer P, Morel O, Fargeaudou Y, et al. Value of pelvic embolisation in the management of severe postpartum haemorrhage due to placenta accreta, increta or percreta. Eur J Radiol 2010. doi: 10.1016/j.ejrad.2010.07.018.
39. Jung H, Shin S, Choi S, et al. Uterine artery embolisation for emergent management of postpartum haemorrhage associated with placenta accreta. Acta Radiol 2011; 52:638-642.
40. Flam F, Karlstrom PO, Carlsson B, Garoff L. Methotrexate treatment for retained placental tissue. Eur J Obstet Gynecol Reprod Biol 1999; 83:127-129.
41. Duenas-Garcia OF, Diaz-Sotomayor M, Rico-Olvera H. Utility of the pulsatility index of the uterine artery and human chorionic gonadotropin in a series of cases of placenta accreta. J Obstet Gynaecol Res 2011; 37:1112-1116.
42. Jaffe R, DuBeshter B, Sherer DM, et al. Failure of methotrexate treatment for term placenta accreta. Am J Obstet Gynecol 1994; 171:558-559.
43. Matsumura N, Fukuoka M, Sagawa N, Fujii S. Changes in the serum levels of human chorionic gonadotropin and the pulsatility index of uterine arteries during conservative management of retained adherent placenta. J Obstet Gynaecol Res 2000; 26:81-87.
44. Jain A, Sepulveda W, Paterson-Brown S. Conservative management of major placenta previa accreta: three case reports. J Obstet Gynaecol 2004; 24 (Suppl 1):S63.
45. Morgan M, Atalla R. Mifepristone and misoprostol for the management of placenta accrete: a new alternative approach. BJOG 2009; 116:1002-1003.
46. El Behery MM, Rasha LE, El Alfy Y. Cell-free placental mRNA in maternal plasma to predict placental invasion in patients with placenta accreta. Int J Gynecol Obstet 2010; 109:30-33.
47. Simonazzi G, Farina A, Curti A, et al. Higher circulating mRNA levels of placental specific genes in a patient with placenta accreta. Prenat Diagn 2011; 31:827-829.